Agiliti, Inc. (AGTI)
NYSE: AGTI · IEX Real-Time Price · USD
10.05
+0.01 (0.10%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Agiliti Revenue
In the year 2023, Agiliti had annual revenue of $1.17B with 4.75% growth. Revenue in the quarter ending December 31, 2023 was $291.99M with 3.66% year-over-year growth.
Revenue (ttm)
$1.17B
Revenue Growth
+4.75%
P/S Ratio
1.16
Revenue / Employee
$202,518
Employees
5,800
Market Cap
1.37B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 1.17B | 53.31M | 4.75% |
Dec 31, 2022 | 1.12B | 82.60M | 7.95% |
Dec 31, 2021 | 1.04B | 265.38M | 34.32% |
Dec 31, 2020 | 773.31M | 160.24M | 26.14% |
Dec 31, 2019 | 613.07M | 47.83M | 8.46% |
Dec 31, 2018 | 565.25M | 50.46M | 9.80% |
Dec 31, 2017 | 514.78M | 35.28M | 7.36% |
Dec 31, 2016 | 479.50M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AdaptHealth | 3.20B |
National HealthCare | 1.14B |
Tilray Brands | 743.25M |
ANI Pharmaceuticals | 486.82M |
Establishment Labs Holdings | 165.15M |
Arcus Biosciences | 117.00M |
Gyre Therapeutics | 113.45M |
Morphic Holding | 521.00K |
AGTI News
- 3 days ago - NBPE Announces Audited 2023 Results and 31 March 2024 Est. NAV - GlobeNewsWire
- 4 days ago - AGILITI INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Sale of Agiliti Inc. - AGTI - Business Wire
- 22 days ago - INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Agiliti, Inc. and Encourages Investors to Contact the Firm - Accesswire
- 24 days ago - ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Agiliti, Inc. and Encourages Investors to Contact the Firm - Accesswire
- 4 weeks ago - Robbins LLP Reminds Investors That It Is Investigating the Acquisition of AGTI - Business Wire
- 5 weeks ago - INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Agiliti, Inc. and Encourages Investors to Contact the Firm - Accesswire
- 5 weeks ago - NBPE Announces February Monthly NAV Estimate - GlobeNewsWire
- 5 weeks ago - IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against Agiliti, Inc. and Encourages Investors to Contact the Firm - Accesswire